Desmoplastic reaction in the microenvironment of head and neck and other solid tumors: the therapeutic barrier

Head and neck squamous cell carcinoma (HNSCC) remains a challenge due to limited prognostic biomarkers and therapeutic options. The tumor microenvironment (TME), particularly the desmoplastic reaction (DR) characterized by stromal fibrosis, plays a crucial role in cancer progression and resistance t...

Full description

Saved in:
Bibliographic Details
Main Authors: Kohei Okuyama, Maiko Tsuchiya, Kala Chand Debnath, Shajedul Islam, Souichi Yanamoto
Format: Article
Language:English
Published: SAGE Publishing 2025-02-01
Series:Therapeutic Advances in Medical Oncology
Online Access:https://doi.org/10.1177/17588359251317144
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1823865433926664192
author Kohei Okuyama
Maiko Tsuchiya
Kala Chand Debnath
Shajedul Islam
Souichi Yanamoto
author_facet Kohei Okuyama
Maiko Tsuchiya
Kala Chand Debnath
Shajedul Islam
Souichi Yanamoto
author_sort Kohei Okuyama
collection DOAJ
description Head and neck squamous cell carcinoma (HNSCC) remains a challenge due to limited prognostic biomarkers and therapeutic options. The tumor microenvironment (TME), particularly the desmoplastic reaction (DR) characterized by stromal fibrosis, plays a crucial role in cancer progression and resistance to therapy. This review aims to summarize the biological significance of DR in HNSCC initiation, progression, and treatment resistance. Histologically, DR in HNSCC correlates with invasion patterns and clinical outcomes, affecting disease-free and overall survival. The interaction between cancer-associated fibroblasts (CAFs) and TME influences immune responses, including resistance to immunotherapy. Notably, human papillomavirus-driven HNSCC exhibits distinct DR characteristics that further influence the prognosis. DR promotes epithelial-mesenchymal transition and cancer cell invasion through CAF-mediated extracellular matrix remodeling and signaling pathways such as transforming growth factor-beta. DR also affects bone invasion and chemotherapy resistance by modulating stromal responses. Therapeutic strategies targeting DR and stromal components show promise in overcoming therapeutic resistance including resistance to immune checkpoint inhibitors. Understanding the role of DR in HNSCC biology and its impact on treatment response is critical to developing effective therapeutic interventions.
format Article
id doaj-art-ab9a487303f042c684a6cd56912d1112
institution Kabale University
issn 1758-8359
language English
publishDate 2025-02-01
publisher SAGE Publishing
record_format Article
series Therapeutic Advances in Medical Oncology
spelling doaj-art-ab9a487303f042c684a6cd56912d11122025-02-08T07:03:48ZengSAGE PublishingTherapeutic Advances in Medical Oncology1758-83592025-02-011710.1177/17588359251317144Desmoplastic reaction in the microenvironment of head and neck and other solid tumors: the therapeutic barrierKohei OkuyamaMaiko TsuchiyaKala Chand DebnathShajedul IslamSouichi YanamotoHead and neck squamous cell carcinoma (HNSCC) remains a challenge due to limited prognostic biomarkers and therapeutic options. The tumor microenvironment (TME), particularly the desmoplastic reaction (DR) characterized by stromal fibrosis, plays a crucial role in cancer progression and resistance to therapy. This review aims to summarize the biological significance of DR in HNSCC initiation, progression, and treatment resistance. Histologically, DR in HNSCC correlates with invasion patterns and clinical outcomes, affecting disease-free and overall survival. The interaction between cancer-associated fibroblasts (CAFs) and TME influences immune responses, including resistance to immunotherapy. Notably, human papillomavirus-driven HNSCC exhibits distinct DR characteristics that further influence the prognosis. DR promotes epithelial-mesenchymal transition and cancer cell invasion through CAF-mediated extracellular matrix remodeling and signaling pathways such as transforming growth factor-beta. DR also affects bone invasion and chemotherapy resistance by modulating stromal responses. Therapeutic strategies targeting DR and stromal components show promise in overcoming therapeutic resistance including resistance to immune checkpoint inhibitors. Understanding the role of DR in HNSCC biology and its impact on treatment response is critical to developing effective therapeutic interventions.https://doi.org/10.1177/17588359251317144
spellingShingle Kohei Okuyama
Maiko Tsuchiya
Kala Chand Debnath
Shajedul Islam
Souichi Yanamoto
Desmoplastic reaction in the microenvironment of head and neck and other solid tumors: the therapeutic barrier
Therapeutic Advances in Medical Oncology
title Desmoplastic reaction in the microenvironment of head and neck and other solid tumors: the therapeutic barrier
title_full Desmoplastic reaction in the microenvironment of head and neck and other solid tumors: the therapeutic barrier
title_fullStr Desmoplastic reaction in the microenvironment of head and neck and other solid tumors: the therapeutic barrier
title_full_unstemmed Desmoplastic reaction in the microenvironment of head and neck and other solid tumors: the therapeutic barrier
title_short Desmoplastic reaction in the microenvironment of head and neck and other solid tumors: the therapeutic barrier
title_sort desmoplastic reaction in the microenvironment of head and neck and other solid tumors the therapeutic barrier
url https://doi.org/10.1177/17588359251317144
work_keys_str_mv AT koheiokuyama desmoplasticreactioninthemicroenvironmentofheadandneckandothersolidtumorsthetherapeuticbarrier
AT maikotsuchiya desmoplasticreactioninthemicroenvironmentofheadandneckandothersolidtumorsthetherapeuticbarrier
AT kalachanddebnath desmoplasticreactioninthemicroenvironmentofheadandneckandothersolidtumorsthetherapeuticbarrier
AT shajedulislam desmoplasticreactioninthemicroenvironmentofheadandneckandothersolidtumorsthetherapeuticbarrier
AT souichiyanamoto desmoplasticreactioninthemicroenvironmentofheadandneckandothersolidtumorsthetherapeuticbarrier